{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:12:58Z","timestamp":1778911978375,"version":"3.51.4"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010667","name":"Horizon 2020 Industrial Leadership","doi-asserted-by":"publisher","award":["721098"],"award-info":[{"award-number":["721098"]}],"id":[{"id":"10.13039\/100010667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZI-1143\/HU441"],"award-info":[{"award-number":["ZI-1143\/HU441"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016300","name":"Octapharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016819","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpx.2025.100432","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:10:52Z","timestamp":1761855052000},"page":"100432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhalative polyclonal immunoglobulin G for the prevention of respiratory infections: A comprehensive in vitro assessment"],"prefix":"10.1016","volume":"10","author":[{"given":"Rebecca","family":"Rittersberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Covini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruthi","family":"Kalgudde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janik","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska Magdalena","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Koslowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Dabbars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Salcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Blayac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"R\u00f6misch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Mur\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Knoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali \u00d6nder","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otmar","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Schindowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2025.100432_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-012-9878-0","article-title":"Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody","volume":"14","author":"Agarkhed","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2025.100432_bb0010","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-014-1541-x","article-title":"Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics","volume":"32","author":"Ahmadi","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011883","article-title":"Molecular and structural basis of oligopeptide recognition by the Ami transporter system in pneumococci","volume":"20","author":"Alcorlo","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpx.2025.100432_bb0020","author":"Antimicrobial resistance"},{"key":"10.1016\/j.ijpx.2025.100432_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/ejp.2014.00087","article-title":"Jet, Ultrasonic, and Mesh Nebulizers: an Evaluation of Nebulizers for Better Clinical Outcomes","volume":"16","author":"Ari","year":"2014","journal-title":"Eur. J. Pulmonol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejpb.2018.04.005","article-title":"Surfactants as stabilizers for biopharmaceuticals: an insight into the molecular mechanisms for inhibition of protein aggregation","volume":"128","author":"Arsiccio","year":"2018","journal-title":"Eur. J. Pharmaceut. Biopharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0035","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4187\/respcare.01450","article-title":"A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction","volume":"57","author":"Arunthari","year":"2012","journal-title":"Respir. Care"},{"key":"10.1016\/j.ijpx.2025.100432_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2976\/1.2760023","article-title":"Characterization of the nucleation barriers for protein aggregation and amyloid formation","volume":"1","author":"Auer","year":"2007","journal-title":"HFSP J."},{"key":"10.1016\/j.ijpx.2025.100432_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00257745","article-title":"Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice","volume":"9","author":"Azmin","year":"1982","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1152\/japplphysiol.00527.2002","article-title":"Local particle deposition patterns may play a key role in the development of lung cancer","volume":"94","author":"Balashazy","year":"2003","journal-title":"J. Appl. Physiol. (Bethesda, Md. 1985)"},{"key":"10.1016\/j.ijpx.2025.100432_bb0055","article-title":"Modulation of Immune responses by Particle size and Shape","volume":"11","author":"Baranov","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0060","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1038\/ncomms4842","article-title":"Structural basis of PcsB-mediated cell separation in Streptococcus pneumoniae","volume":"5","author":"Bartual","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2025.100432_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010183","article-title":"Influenza treatment: limitations of antiviral therapy and advantages of drug combination therapy","volume":"11","author":"Batool","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijpx.2025.100432_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.copbio.2008.10.002","article-title":"Antibodies for the treatment of bacterial infections: current experience and future prospects","volume":"19","author":"Bebbington","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2013.11.036","article-title":"On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery","volume":"461","author":"Beck-Broichsitter","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0080","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2025.100432_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.04.00135703","article-title":"Atypical pathogens and respiratory tract infections","volume":"24","author":"Blasi","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpx.2025.100432_bb0090","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/17425247.2018.1503251","article-title":"Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?","volume":"15","author":"Bodier-Montagutelli","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2025.100432_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2020.04.006","article-title":"Protein stability during nebulization: mind the collection step!","volume":"152","author":"Bodier-Montagutelli","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01720610-201210000-00005","article-title":"Respiratory tract infections: Emerging viral pathogens","volume":"25","author":"Borchardt","year":"2012","journal-title":"JAAPA"},{"key":"10.1016\/j.ijpx.2025.100432_bb0105","article-title":"Inhaled Therapy in respiratory Disease: the complex Interplay of Pulmonary Kinetic Processes","volume":"2018","author":"Borghardt","year":"2018","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.ijpx.2025.100432_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10875-017-0424-4","article-title":"Efficacy and safety of human intravenous immunoglobulin 10% (Panzyga\u00ae) in patients with primary immunodeficiency diseases: a two-stage, multicenter, prospective, open-label study","volume":"37","author":"Borte","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/mabs.2.3.11782","article-title":"Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies","volume":"2","author":"Brennan","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.ijpx.2025.100432_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/atmos11020137","article-title":"Prediction of aerosol deposition in the human respiratory tract via computational models: a review with recent updates","volume":"11","author":"Bui","year":"2020","journal-title":"Atmosphere"},{"key":"10.1016\/j.ijpx.2025.100432_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s44222-022-00012-6","article-title":"Biomaterials for intranasal and inhaled vaccine delivery","volume":"1","author":"Cahn","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.ijpx.2025.100432_bb0130","article-title":"Joining forces against Antibiotic Resistance: the one Health solution","volume":"12","author":"Cella","year":"2023","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"10.1016\/j.ijpx.2025.100432_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1208\/s12249-023-02579-8","article-title":"Aerosolization performance of immunoglobulin g by jet and mesh nebulizers","volume":"24","author":"Chang","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2025.100432_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.125856","article-title":"Aerosol deposition and airflow dynamics in healthy and asthmatic human airways during inhalation","volume":"416","author":"Chen","year":"2021","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.ijpx.2025.100432_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jamp.2020.29029.cd","article-title":"Deposition mechanisms","volume":"33","author":"Darquenne","year":"2020","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpx.2025.100432_bb0150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41385-022-00500-3","article-title":"Correction: Cellular and functional heterogeneity of the airway epithelium","volume":"15","author":"Davis","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0155","author":"Dianova Int"},{"key":"10.1016\/j.ijpx.2025.100432_bb0160","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1074\/jbc.M310528200","article-title":"Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium","volume":"279","author":"Elm","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2025.100432_bb0165","series-title":"English: 11.0\u201311.2, 11th ed. Deutscher Apotheker Verlag","author":"European Pharmacopoeia","year":"2022"},{"key":"10.1016\/j.ijpx.2025.100432_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13346-018-0580-y","article-title":"Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats","volume":"9","author":"Gao","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0175","author":"Garidel","year":"2009"},{"key":"10.1016\/j.ijpx.2025.100432_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12020154","article-title":"Prevention and Treatment strategies for respiratory Syncytial Virus (RSV)","volume":"12","author":"Gatt","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ijpx.2025.100432_bb0185","series-title":"Immunopathology in Toxicology and Drug Development: Volume 2, Organ Systems","first-page":"419","article-title":"Immunopathology of the respiratory System","author":"Greeley","year":"2017"},{"key":"10.1016\/j.ijpx.2025.100432_bb0190","series-title":"Testing for cytotoxicity: The \u201cwell-established\u201d EN ISO 10993-5","author":"Grosu","year":"2022"},{"key":"10.1016\/j.ijpx.2025.100432_bb0195","series-title":"Pharmacology","first-page":"1","article-title":"History of pharmacology\u2014from antiquity to the twentieth century","author":"Hacker","year":"2009"},{"key":"10.1016\/j.ijpx.2025.100432_bb0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0300-483X(03)00043-X","article-title":"Species differences in the structure and function of the immune system","volume":"188","author":"Haley","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpx.2025.100432_bb0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CVI.13.2.208-213.2006","article-title":"Neutralizing antibodies and persistence of immunity following anthrax vaccination","volume":"13","author":"Hanson","year":"2006","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"10.1016\/j.ijpx.2025.100432_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae216","article-title":"Serological profiling of pneumococcal proteins reveals unique patterns of acquisition, maintenance and waning of antibodies throughout life","author":"He","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpx.2025.100432_bb0215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1208\/s12249-008-9072-6","article-title":"Embryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airways","volume":"9","author":"Henning","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2025.100432_bb0220","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/B:PHAM.0000029275.41323.a6","article-title":"Structure-immunogenicity relationships of therapeutic proteins","volume":"21","author":"Hermeling","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2014.10.003","article-title":"Protein stability in pulmonary drug delivery via nebulization","volume":"93","author":"Hertel","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2025.100432_bb0230","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/s41467-017-01720-z","article-title":"Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae","volume":"8","author":"He\u00df","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2025.100432_bb0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0240","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/09031936.00141514","article-title":"The innate immune function of airway epithelial cells in inflammatory lung disease","volume":"45","author":"Hiemstra","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpx.2025.100432_bb0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11096-014-0043-6","article-title":"Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study","volume":"37","author":"Hogan","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40360-023-00711-9","article-title":"Evaluation of antibody drug delivery efficiency via nebulizer in various airway models and breathing patterns","volume":"24","author":"Hong","year":"2023","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0255","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.xphs.2023.02.010","article-title":"Protein aggregates in inhaled biologics: challenges and considerations","volume":"112","author":"Ibrahim","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0260","series-title":"Human Respiratory Tract Model for Radiological Protection","author":"ICRP","year":"1994"},{"key":"10.1016\/j.ijpx.2025.100432_bb0265","first-page":"31","article-title":"Position paper: recommendation on the adoption of breathing patterns for infants and small children in general chapter 2.9.44. Preparations for nebulisation","volume":"2008","author":"Jauernig","year":"2008","journal-title":"Pharmeuropa Scientific Notes"},{"key":"10.1016\/j.ijpx.2025.100432_bb0270","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.1074\/jbc.M111.330902","article-title":"Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses","volume":"287","author":"Joubert","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2025.100432_bb0275","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0280","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.xphs.2018.06.029","article-title":"Submicron size particles of a murine monoclonal antibody are more immunogenic than soluble oligomers or micron size particles upon subcutaneous administration in mice","volume":"107","author":"Kijanka","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0285","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","article-title":"The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model","volume":"32","author":"Kreft","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030107","article-title":"Allogenic Fc domain-facilitated uptake of igg in nasal lamina propria: friend or foe for intranasal CNS delivery?","volume":"10","author":"Ladel","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2025.100432_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080367","article-title":"Improved in vitro model for intranasal mucosal drug delivery: primary olfactory and respiratory epithelial cells compared with the permanent nasal cell line RPMI 2650","volume":"11","author":"Ladel","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2025.100432_bb0300","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.4049\/jimmunol.180.9.6222","article-title":"Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region","volume":"180","author":"LaRocca","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0305","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/en.2010-0457","article-title":"Inhaled insulin forms toxic pulmonary amyloid aggregates","volume":"151","author":"Lasagna-Reeves","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijpx.2025.100432_bb0310","doi-asserted-by":"crossref","DOI":"10.23937\/2572-4061.1510022","article-title":"Evaluation of lung cell toxicity of surfactants for inhalation route","volume":"5","author":"Lindenberg","year":"2019","journal-title":"J. Toxicol. Risk Assess."},{"key":"10.1016\/j.ijpx.2025.100432_bb0315","article-title":"Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-415847-4.00071-9","article-title":"Passive immunization","volume":"1403\u20131434","author":"Marcotte","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0325","doi-asserted-by":"crossref","DOI":"10.1007\/s44164-024-00079-y","article-title":"Characterization of a primary cellular airway model for inhalative drug delivery in comparison with the established permanent cell lines CaLu3 and RPMI 2650","author":"Martin","year":"2024","journal-title":"In Vitro Models"},{"key":"10.1016\/j.ijpx.2025.100432_bb0330","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-020-00014-z","article-title":"Developing inhaled protein therapeutics for lung diseases","volume":"1","author":"Matthews","year":"2020","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ijpx.2025.100432_bb0335","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2022.11.006","article-title":"Inhaled IgG1 antibodies: the buffering system is an important driver of stability during mesh-nebulization","volume":"181","author":"Mayor","year":"2022","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ijpx.2025.100432_bb0340","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/08958378.2013.769037","article-title":"Inhaled biopharmaceutical drug development: nonclinical considerations and case studies","volume":"25","author":"McElroy","year":"2013","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0345","first-page":"33","article-title":"Biochemical characterization and stability of immune globulin intravenous 10% liquid (Panzyga\u00ae)","volume":"45","author":"Mersich","year":"2017","journal-title":"Biologicals J. Int. Assoc. Biol. Standardization"},{"key":"10.1016\/j.ijpx.2025.100432_bb0350","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ijpx.2025.100432_bb0355","first-page":"275","article-title":"Safety assessment of excipients (SAFE) for orally inhaled drug products","volume":"37","author":"Metz","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.ijpx.2025.100432_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103577","article-title":"Technical report: xMAPr - High-dynamic-range (HDR) quantification of antigen-specific antibody binding","volume":"212","author":"Meyer","year":"2020","journal-title":"J. Proteomics"},{"key":"10.1016\/j.ijpx.2025.100432_bb0365","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaerosci.2016.01.018","article-title":"Improvements and additions to the multiple path particle dosimetry model","volume":"99","author":"Miller","year":"2016","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0370","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-0691.2010.03183.x","article-title":"Streptococcus pneumoniae: virulence factors and variation","volume":"16","author":"Mitchell","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpx.2025.100432_bb0375","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0380","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijmm.2007.04.002","article-title":"Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide","volume":"297","author":"M\u00fcller-Loennies","year":"2007","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"10.1016\/j.ijpx.2025.100432_bb0385","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/514093","article-title":"Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae","volume":"176","author":"Nahm","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpx.2025.100432_bb0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jps.22790","article-title":"Classification of protein aggregates","volume":"101","author":"Narhi","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0400","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.4209\/aaqr.2020.02.0067","article-title":"Particle deposition in human lung airways: effects of airflow, particle size, and mechanisms","volume":"20","author":"Ou","year":"2020","journal-title":"Aerosol Air Qual. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0405","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1007\/s00253-021-11488-4","article-title":"Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections","volume":"105","author":"Parray","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0410","series-title":"IEEE 20th International Conference on Bioinformatics and Bioengineering (BIBE) 2020","first-page":"411","article-title":"Aerosol particle deposition in the lungs: effect of breathing patterns","author":"Pilou","year":"2020"},{"key":"10.1016\/j.ijpx.2025.100432_bb0415","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/027868299304174","article-title":"The Influence of Particle size distribution and Surface Roughness of carrier Particles on the in vitro Properties of Dry Powder Inhalations","volume":"31","author":"Podczeck","year":"1999","journal-title":"Aerosol Sci. Tech."},{"key":"10.1016\/j.ijpx.2025.100432_bb0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2017.09.027","article-title":"A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery","volume":"532","author":"R\u00f6hm","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0435","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03639045.2011.592533","article-title":"Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin","volume":"38","author":"Ruan","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coviro.2012.03.009","article-title":"The mucosal immune system of the respiratory tract","volume":"2","author":"Sato","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-422X-7-28","article-title":"Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient","volume":"7","author":"Schieffelin","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.ijpx.2025.100432_bb0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jprot.2017.01.008","article-title":"Characterization of human and Staphylococcus aureus proteins in respiratory mucosa by in vivo- and immunoproteomics","volume":"155","author":"Schmidt","year":"2017","journal-title":"J. Proteomics"},{"key":"10.1016\/j.ijpx.2025.100432_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030671","article-title":"Aggregates associated with instability of antibodies during aerosolization induce adverse immunological effects","volume":"14","author":"S\u00e9cher","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2025.100432_bb0460","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00702-20","article-title":"Sputum proteome signatures of mechanically ventilated intensive care unit patients distinguish samples with or without anti-pneumococcal activity","volume":"6","author":"Seinen","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.ijpx.2025.100432_bb0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2023.01.013","article-title":"Air-liquid interface (ALI) impact on different respiratory cell cultures","volume":"184","author":"Silva","year":"2023","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ijpx.2025.100432_bb0470","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.xphs.2017.08.011","article-title":"Effect of polysorbate 20 and polysorbate 80 on the higher-order structure of a monoclonal antibody and its fab and Fc fragments probed using 2D nuclear magnetic resonance spectroscopy","volume":"106","author":"Singh","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3346\/jkms.2013.28.1.4","article-title":"Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance","volume":"28","author":"Song","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0480","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10096-022-04446-z","article-title":"Streptococcus pneumoniae colonization in health care professionals at a tertiary university pediatric hospital","volume":"41","author":"Steurer","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijpx.2025.100432_bb0485","doi-asserted-by":"crossref","DOI":"10.1186\/1753-6561-9-S9-O11","article-title":"Protein aerosol for intranasal nose to brain (N2B) delivery","volume":"9","author":"St\u00fctzle","year":"2015","journal-title":"BMC Proc."},{"key":"10.1016\/j.ijpx.2025.100432_bb0490","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1021\/nn800508f","article-title":"A nanoengineering approach for investigation and regulation of protein immobilization","volume":"2","author":"Tan","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2025.100432_bb0495","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1039\/D3CC04311H","article-title":"Interface-mediated protein aggregation","volume":"59","author":"Tao","year":"2023","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.ijpx.2025.100432_bb0500","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/jps.24379","article-title":"Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting","volume":"104","author":"Telikepalli","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0505","author":"The top 10 causes of death"},{"key":"10.1016\/j.ijpx.2025.100432_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122490","article-title":"In vitro and in vivo immunogenicity assessment of protein aggregate characteristics","volume":"631","author":"Thorlaksen","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0515","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal vaccination: onward and upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpx.2025.100432_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000028109","article-title":"Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases","volume":"68","author":"Tschernig","year":"2000","journal-title":"Pathobiology"},{"key":"10.1016\/j.ijpx.2025.100432_bb0525","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40259-023-00596-4","article-title":"Review and update of active and passive immunization against respiratory syncytial virus","volume":"37","author":"Verwey","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijpx.2025.100432_bb0530","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12931-019-1057-3","article-title":"Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates","volume":"20","author":"Vonarburg","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijpx.2025.100432_bb0535","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3389\/fimmu.2018.02405","article-title":"Intranasal vaccination with lipoproteins confers protection against pneumococcal colonisation","volume":"9","author":"Vo\u00df","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000336839","article-title":"Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab","volume":"159","author":"Vultaggio","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.040","article-title":"Immunogenicity of protein aggregates-concerns and realities","volume":"431","author":"Wang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2025.100432_bb0550","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41541-023-00773-0","article-title":"Outlook of pandemic preparedness in a post-COVID-19 world","volume":"8","author":"Williams","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijpx.2025.100432_bb0555","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.xphs.2022.02.009","article-title":"Industry perspective on the use and characterization of polysorbates for biopharmaceutical products part 1: Survey report on current state and common practices for handling and control of polysorbates","volume":"111","author":"Wuchner","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0560","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8240(80)80060-7","article-title":"Models of human lung airways and their application to inhaled particle deposition","volume":"42","author":"Yeh","year":"1980","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0565","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/000348940010900612","article-title":"Secretory differentiation of serially passaged normal human nasal epithelial cells by retinoic acid: expression of mucin and lysozyme","volume":"109","author":"Yoon","year":"2000","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.ijpx.2025.100432_bb0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/viru.1.5.12705","article-title":"Enhancement of bacterial virulence by antibody neutralization of immune-activating toxins","volume":"1","author":"Yoong","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.ijpx.2025.100432_bb0575","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2203\/dose-response.13-024.Koukourakis","article-title":"Evaluation of the alamarblue assay for adherent cell irradiation experiments","volume":"12","author":"Zachari","year":"2014","journal-title":"Dose-Response"},{"key":"10.1016\/j.ijpx.2025.100432_bb0580","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41541-021-00413-5","article-title":"Pneumococcal capsule blocks protection by immunization with conserved surface proteins","volume":"6","author":"Zangari","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijpx.2025.100432_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106724","article-title":"Investigating distributions of inhaled aerosols in the lungs of post-COVID-19 clusters through a unified imaging and modeling approach","volume":"195","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpx.2025.100432_bb0590","first-page":"1","article-title":"Cultured Human Airway Epithelial Cells (Calu-3): a Model of Human respiratory Function, Structure, and Inflammatory responses","volume":"2010","author":"Zhu","year":"2010","journal-title":"Crit. Care Res. Prac."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:04:16Z","timestamp":1778911456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156725001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":116,"alternative-id":["S2590156725001173"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100432","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalative polyclonal immunoglobulin G for the prevention of respiratory infections: A comprehensive in vitro assessment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100432"}}